167 related articles for article (PubMed ID: 19548126)
1. Bone marrow hyaluronan and reticulin in patients with malignant disorders.
Sundström G; Hultdin M; Engström-Laurent A; Dahl IM
Med Oncol; 2010 Sep; 27(3):618-23. PubMed ID: 19548126
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow hyaluronan distribution in patients with acute myeloid leukemia.
Sundström G; Dahl IM; Hultdin M; Lundström B; Wahlin A; Engström-Laurent A
Med Oncol; 2005; 22(1):71-8. PubMed ID: 15750199
[TBL] [Abstract][Full Text] [Related]
3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
4. Localisation and distribution of hyaluronan in normal bone marrow matrix: a novel method to evaluate impending fibrosis?
Sundström G; Löfvenberg E; Hassan I; Engström-Laurent A
Eur J Haematol; 2002 Apr; 68(4):194-202. PubMed ID: 12071934
[TBL] [Abstract][Full Text] [Related]
5. Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis.
Colović MD; Wiernik PH; Janković GM; Vidović AD; Janosević S; Basara NM
Eur J Haematol; 1999 Mar; 62(3):155-9. PubMed ID: 10089892
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.
Iványi JL; Mahunka M; Papp A; Kiss A; Telek B
Haematologia (Budap); 1994; 26(2):75-86. PubMed ID: 7890265
[TBL] [Abstract][Full Text] [Related]
7. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Niederle N; Zirbes TK; Schmidt M; Dammasch J; Meuter BR; Leder LD; Kloke O; Diehl V
Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
[TBL] [Abstract][Full Text] [Related]
8. Follow-up study on bone marrow reticulin fibrosis in AML.
Thiele J; Grashof K; Fisher R
Anal Cell Pathol; 1991 Jul; 3(4):225-31. PubMed ID: 1883746
[TBL] [Abstract][Full Text] [Related]
9. Myelofibrosis in cats with myelodysplastic syndrome and acute myelogenous leukemia.
Blue JT
Vet Pathol; 1988 Mar; 25(2):154-60. PubMed ID: 2834859
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow reticulin and collagen content in patients with adult chronic immune thrombocytopenic purpura: a Danish nationwide study.
Ettrup MS; Jensen AØ; Engebjerg MC; Farkas DK; Nørgaard M; Cha S; Zhao S; Johansen P; Sørensen HT
Am J Hematol; 2010 Dec; 85(12):930-4. PubMed ID: 20981681
[TBL] [Abstract][Full Text] [Related]
11. [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow].
Bedekovics J; Méhes G
Orv Hetil; 2014 Mar; 155(10):367-75. PubMed ID: 24583557
[TBL] [Abstract][Full Text] [Related]
12. Myelofibrosis in primary myelodysplastic syndromes: clinical and biological significance.
Marisavljević D; Rolović Z; Cemerikić V; Bosković D; Colović M
Med Oncol; 2004; 21(4):325-31. PubMed ID: 15579916
[TBL] [Abstract][Full Text] [Related]
13. Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases.
Pagliuca A; Layton DM; Manoharan A; Gordon S; Green PJ; Mufti GJ
Br J Haematol; 1989 Apr; 71(4):499-504. PubMed ID: 2640542
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients.
Gianelli U; Fiori S; Cattaneo D; Bossi A; Cortinovis I; Bonometti A; Ercoli G; Bucelli C; Orofino N; Bulfamante G; Iurlo A
Histopathology; 2017 Dec; 71(6):897-908. PubMed ID: 28710830
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres.
Kuter DJ; Bain B; Mufti G; Bagg A; Hasserjian RP
Br J Haematol; 2007 Nov; 139(3):351-62. PubMed ID: 17910625
[TBL] [Abstract][Full Text] [Related]
16. Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment.
Hultdin M; Sundström G; Wahlin A; Lundström B; Samuelsson J; Birgegård G; Engström-Laurent A
Med Oncol; 2007; 24(1):63-70. PubMed ID: 17673813
[TBL] [Abstract][Full Text] [Related]
17. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.
Thiele J; Hoeppner B; Zankovich R; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1989; 415(3):191-202. PubMed ID: 2503923
[TBL] [Abstract][Full Text] [Related]
18. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
Duhamel G; Stachowiak J
Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348
[TBL] [Abstract][Full Text] [Related]
19. STROMAL CHANGES IN LEUKAEMIC AND RELATED BONE MARROW PROLIFERATIONS.
SANERKIN NG
J Clin Pathol; 1964 Sep; 17(5):541-7. PubMed ID: 14207789
[TBL] [Abstract][Full Text] [Related]
20. The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia.
Dekmezian R; Kantarjian HM; Keating MJ; Talpaz M; McCredie KB; Freireich EJ
Cancer; 1987 May; 59(10):1739-43. PubMed ID: 2435399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
